Chief executive Tara Comonte said the brand ‘wasn’t as quick to medical weight loss solutions’ as some other firms in the US.

Let’s dig into the relative performance of WeightWatchers (NASDAQ:WW) and its peers as we unravel the now-completed Q4 ...

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause ...

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis of WW stock now.

An iconic weight-loss company has emerged from several months of bankruptcy with a revamped business strategy.

WeightWatchers CEO Tara Comonte said such support for members using weight-loss drugs should appeal to health insurers and employers who pay for health benefits as they seek more sustainable ...

Existing directors Tara Comonte and Julie Bornstein, CEO and Founder of Daydream, will also continue to serve on the new Board.

“This is a pivotal moment for WeightWatchers,” said Tara Comonte, Chief Executive Officer of WeightWatchers. “With renewed financial strength, an expanded leadership team, and the addition ...

Among the appointments were Mike Mason, former president of Eli Lilly's diabetes and obesity business. Existing directors Tara Comonte and Julie Bornstein will continue to serve on the new board.

In its statement Tuesday, WW said that it now has "significantly enhanced" financial flexibility. "This is a pivotal moment for WeightWatchers," said WW Chief Executive Tara Comonte.

WeightWatchers’ chief executive Tara Comonte had said it needed to transform amid a “rapidly evolving weight managing landscape”. Competition has grown fiercely with demand for prescription ...